Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial

Figure 2

Stages of the TREAT-ME1 study. The TREAT-ME1 trial will be conducted in two stages, which are interrupted by an interim-analysis. Phase II will include two patient groups. Group 1 will be treated by the same treatment schedule as in phase I. Group 2 will consist of patient that are eligible for surgical resection of the tumor but that need neoadjuvant therapy.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us